Based on the quantitative studies reported here, particularly the observations in rats implanted with IL-1-containing pellets, one could predict that any neural condition involving IL-1 overexpression would exhibit concomitant pernicious alterations in the substrates associated with the hallmark neuropathologies in either AD or PD, alone or together. Here, IL1B is linked to Parkinson disease.